Molecular Biomarkers of Vascular Dysfunction in Obstructive Sleep Apnea

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Kaczmarek, Elzbieta ^a   Bakker, Jessie P ^b   Clarke, Douglas N ^a   Csizmadia, Eva ^a   Kocher, Olivier ^a   Veves, Aristidis ^a   Tecilazich, Francesco ^a   O'Donnell, Christopher P ^c   Ferran, Christiane ^a   Malhotra, Atul ^b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MOLECULAR MARKER; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSCILLATION; OXYGEN DESATURATION; OXYGEN SATURATION; PROTEIN EXPRESSION; REOXYGENATION; RISK ASSESSMENT; SKIN BIOPSY; SLEEP DISORDERED BREATHING; VASCULAR DISEASE;

ADULT; AGED; ANIMALS; ANOXIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION PROFILING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICROCIRCULATION; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; YOUNG ADULT;

EID: 84880826436     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070559     Document Type: Article

References (68)

1. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, et al. (2013) Increased Prevalence of Sleep-Disordered Breathing in Adults. Am Journal Epidemiol.
2. Malhotra A, Loscalzo J, (2009) Sleep and cardiovascular disease: an overview. Prog Cardiovasc Dis 51: 279-284.
3. Atkeson A, Yeh SY, Malhotra A, Jelic S, (2009) Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis 51: 351-362.
4. Feng J, Zhang D, Chen B, (2012) Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath 16: 283-294.
5. Gozal D, Kheirandish-Gozal L, (2008) Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 177: 369-375.
6. Lavie L, (2003) Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep medicine reviews 7: 35-51.
7. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, et al. (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94: 179-184.
8. Ryan S, Taylor CT, McNicholas WT, (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64: 631-636.
9. Ryan S, McNicholas WT, (2009) Inflammatory cardiovascular risk markers in obstructive sleep apnoea syndrome. Cardiovasc Hematol Agents Med Chem 7: 76-81.
10. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, et al. (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117: 2270-2278.
11. Testelmans D, Tamisier R, Barone-Rochette G, Baguet JP, Roux-Lombard P, et al. (2013) Profile of circulating cytokines: Impact of OSA, obesity and acute cardiovascular events. Cytokine 62: 210-216.
12. Toffoli S, Roegiers A, Feron O, Van Steenbrugge M, Ninane N, et al. (2009) Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1. Angiogenesis 12: 47-67.
13. Yuan G, Nanduri J, Khan S, Semenza GL, Prabhakar NR, (2008) Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol 217: 674-685.
14. Wang Z, Si LY, (2013) Hypoxia-inducible factor-1alpha and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats. Upsala journal of medical sciences 118: 65-74.
15. Xu WQ, Yu Z, Xie Y, Huang GQ, Shu XH, et al. (2011) Therapeutic effect of intermittent hypobaric hypoxia on myocardial infarction in rats. Basic Res Cardiol 106: 329-342.
16. Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Levy P, et al. (2009) Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Amer Coll Cardiol 53: 1309-1317.
17. Montesi SB, Bajwa EK, Malhotra A, (2012) Biomarkers of sleep apnea. Chest 142: 239-245.
18. Yim-Yeh S, Rahangdale S, Nguyen AT, Jordan AS, Novack V, et al. (2010) Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function. Sleep 33: 1177-1183.
19. Rahangdale S, Yeh SY, Malhotra A, Veves A, (2009) Therapeutic interventions and oxidative stress in diabetes. Front Biosci 14: 192-209.
20. Veves A, Saouaf R, Donaghue VM, Mullooly CA, Kistler JA, et al. (1997) Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes 46: 1846-1852.
21. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, et al. (2003) Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552: 253-264.
22. Forstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Europ Heart J 33: 829-837, 837a-837d.
23. Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, et al. (2005) Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci U S A 102: 904-908.
24. Huang PL, (2003) Endothelial nitric oxide synthase and endothelial dysfunction. Curr Hypertens Rep 5: 473-480.
25. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM, (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem. 267: 24157-24160.
26. Beyaert R, Heyninck K, Van Huffel S, (2000) A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem Pharmacol 60: 1143-1151.
27. Masinovsky B, Urdal D, Gallatin WM, (1990) IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immunol 145: 2886-2895.
28. Fries JW, Williams AJ, Atkins RC, Newman W, Lipscomb MF, et al. (1993) Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Amer J Pathol 143: 725-737.
29. Semenza GL, (2000) HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev 19: 59-65.
30. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
31. Levy P, Pepin JL, Arnaud C, Baguet JP, Dematteis M, et al. (2009) Obstructive sleep apnea and atherosclerosis. Progr Cardiovasc Dis 51: 400-410.
32. Sessa WC, (2009) Molecular control of blood flow and angiogenesis: role of nitric oxide. J Thromb Haemost: JTH 7Suppl 1: 35-37.
33. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, et al. (1996) A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem 271: 18068-18073.
34. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, et al. (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102: 2607-2610.
35. Frost MT, Wang Q, Moncada S, Singer M, (2005) Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regulat Integrat Comp Physiol 288: R394-400.
36. Taylor CT, Moncada S, (2010) Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscl Thromb Vasc Biol 30: 643-647.
37. Ho JJ, Man HS, Marsden PA, (2012) Nitric oxide signaling in hypoxia. J Mol Med 90: 217-231.
38. Galkin A, Higgs A, Moncada S, (2007) Nitric oxide and hypoxia. Ess Biochem 43: 29-42.
39. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, et al. (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108: 1341-1348.
40. Chu S, Bohlen HG, (2004) High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism. Am J Physiol Renal Physiol 287: F384-392.
41. Tagaito Y, Polotsky VY, Campen MJ, Wilson JA, Balbir A, et al. (2001) A model of sleep-disordered breathing in the C57BL/6J mouse. J Appl Physiol 91: 2758-2766.
42. Arnaud C, Beguin PC, Lantuejoul S, Pepin JL, Guillermet C, et al. (2011) The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. Am J Resp Crit Care Med 184: 724-731.
43. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, et al. (2006) Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Comm 343: 591-596.
44. Gautier E, Arnaud C, Back M, Pepin JL, Petri MH, et al. (2012) Intermittent hypoxia activated cyclooxygenase pathway: role in atherosclerosis. Europ Respir J: official journal of the European Society for Clinical Respiratory Physiology.
45. Zhao HY, Chen BY, Cao J, Feng J, Guo MN, (2007) [Effects of obstructive sleep apnea style intermittent hypoxia on endothelin-1, nitric oxide, and nitric oxide synthase in endothelium: experiment with human umbilical vein endothelial cells]. Zhonghua Yi Xue Za Zhi 87: 2189-2192.
46. Wang B, Yan B, Song D, Ye X, Liu SF, (2013) Chronic intermittent hypoxia down-regulates endothelial nitric oxide synthase expression by an NF-kappaB-dependent mechanism. Sleep Med 14: 165-171.
47. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, et al. (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107: 1129-1134.
48. El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, et al. (2002) Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 121: 1541-1547.
49. Bravo Mde L, Serpero LD, Barcelo A, Barbe F, Agusti A, et al. (2007) Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breathing 11: 177-185.
50. Ramar K, Caples SM, (2011) Vascular changes, cardiovascular disease and obstructive sleep apnea. Future Cardiol 7: 241-249.
51. Jurado-Gamez B, Cabrera CB, Ballesteros LC, Hinojosa CM, Cabrera LM, et al. (2012) Association of cellular adhesion molecules and oxidative stress with endothelial function in obstructive sleep apnea. Intern Med 51: 363-368.
52. Polotsky VY, Savransky V, Bevans-Fonti S, Reinke C, Li J, et al. (2010) Intermittent and Sustained Hypoxia Induce a Similar Gene Expression Profile in the Human Aortic Endothelial Cells. Physiol Genom 41: 306-314.
53. Price DT, Loscalzo J, (1999) Cellular adhesion molecules and atherogenesis. Am J Med 107: 85-97.
54. Longo CR, Arvelo MB, Patel VI, Daniel S, Mahiou J, et al. (2003) A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis. Circulation 108: 1113-1118.
55. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Wrighton CJ, et al. (1998) A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 91: 2249-2258.
56. Daniel S, Arvelo MB, Patel VI, Longo CR, Shrikhande G, et al. (2004) A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 104: 2376-2384.
57. Murat A, Migliavacca E, Hussain SF, Heimberger AB, Desbaillets I, et al. (2009) Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PloS one 4: e5947.
58. Kim JW, Gao P, Liu YC, Semenza GL, Dang CV, (2007) Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 27: 7381-7393.
59. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, et al. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93: 1074-1081.
60. Semenza GL, (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Science's STKE: signal transduction knowledge environment 2007: cm8.
61. Ryan S, Taylor CT, McNicholas WT, (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112: 2660-2667.
62. Jelkmann W, (2001) Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47: 617-623.
63. Bhardwaj S, Roy H, Heikura T, Yla-Herttuala S, (2005) VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries. Europ J Clin Invest 35: 669-676.
64. Morsi WG, Shaker OG, Ismail EF, Ahmed HH, El-Serafi TI, et al. (2006) HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis. Clin Biochem 39: 1057-1062.
65. de la Pena M, Barcelo A, Barbe F, Pierola J, Pons J, et al. (2008) Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome. Respiration 76: 28-32.
66. Gozal D, Lipton AJ, Jones KL, (2002) Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25: 59-65.
67. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F, (2002) Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Resp Crit Care Med 165: 67-70.
68. Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, et al. (2001) Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 98: 1255-1257.